Compounds > bay y3118
Page last updated: 2024-09-03

bay y3118 and sparfloxacin

bay y3118 has been researched along with sparfloxacin in 7 studies

Compound Research Comparison

Studies
(bay y3118)		Trials
(bay y3118)		Recent Studies (post-2010)
(bay y3118)		Studies
(sparfloxacin)		Trials
(sparfloxacin)		Recent Studies (post-2010) (sparfloxacin)
37006946979

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauernfeind, A1
Citron, DM; Goldstein, EJ; Nesbit, CA1
Aldridge, KE1
Borobio, MV; Conejo, M; Perea, EJ; Ramirez, E; Suarez, AI1
Andrews, JM; Brenwald, N; Wise, R1
Verbist, L; Verhaegen, J1
Ahr, HJ; Blotz, A; Blümel, J; Dubertret, L; Michel, L; Moysan, A; Vohr, HW1

Other Studies

7 other study(ies) available for bay y3118 and sparfloxacin

ArticleYear
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:4

    Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones

1993
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Wound Infection

1995
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones

1994
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6

    Topics: Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones

1994
The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Chlamydia; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Lactams; Microbial Sensitivity Tests; Quinolones; Species Specificity; Staphylococcus

1993
Comparative in vitro activity of BAY Y 3118 against selected species.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones

1995
Analyses of cutaneous fluoroquinolones photoreactivity using the integrated model for the differentiation of skin reactions.
    Journal of photochemistry and photobiology. B, Biology, 2000, Volume: 58, Issue:1

    Topics: Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Biomarkers; Cell Membrane; Enoxacin; Female; Fluoroquinolones; Irritants; Mice; Models, Biological; Ofloxacin; Phenotype; Photosensitizing Agents; Quinolones; Skin

2000